CoChat

The Role of Ghrelin/GHS-R1A Signaling in Nonalcohol Drug Addictions

Open access
Sustkova-Fiserova, Magdalena, Charalambous, Chrysostomos, Khryakova, Anna, Certilina, Alina, Lapka, Marek, Šlamberová, Romana · 2022 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.

Abstract

Drug addiction causes constant serious health, social, and economic burden within the human society. The current drug dependence pharmacotherapies, particularly relapse prevention, remain limited, unsatisfactory, unreliable for opioids and tobacco, and even symptomatic for stimulants and cannabinoids, thus, new more effective treatment strategies are researched. The antagonism of the growth hormone secretagogue receptor type A (GHS-R1A) has been recently proposed as a novel alcohol addiction treatment strategy, and it has been intensively studied in experimental models of other addictive drugs, such as nicotine, stimulants, opioids and cannabinoids. The role of ghrelin signaling in these drugs effects has also been investigated. The present review aims to provide a comprehensive overview of preclinical and clinical studies focused on ghrelin’s/GHS-R1A possible involvement in these nonalcohol addictive drugs reinforcing effects and addiction. Although the investigation is still in its early stage, majority of the existing reviewed experimental results from rodents with the addition of few human studies, that searched correlations between the genetic variations of the ghrelin signaling or the ghrelin blood content with the addictive drugs effects, have indicated the importance of the ghrelin’s/GHS-R1As involvement in the nonalcohol abused drugs pro-addictive effects. Further research is necessary to elucidate the exact involved mechanisms and to verify the future potential utilization and safety of the GHS-R1A antagonism use for these drug addiction therapies, particularly for reducing the risk of relapse.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms23020761

Cites

234 of 234 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 234 references

Cited by

See all 14

Metadata

Authors
Sustkova-Fiserova, M., Charalambous, C., Khryakova, A., Certilina, A., Lapka, M., & Šlamberová, R.
Affiliations
  • Department of Pharmacology, Third Faculty of Medicine, Charles University, Ruska 87, 100 00 Prague, Czech Republic
  • Charles University (CZ)
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2022-01-11
Volume
23
Issue
2
Pages
761
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4206420944
Cited by
12
References
234
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 4 · 2022: 3
FWCI
0.36
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Univerzita Karlova v Praze (260533/SVV/2021, PROGRES Q35)
  • Grantová Agentura České Republiky (GA21-30795S)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
ghrelin, GHS-R1a, growth hormone secretagogue receptor, drug addiction, nicotine dependence, opioid use disorder, stimulant use disorder, relapse prevention, addiction pharmacotherapy, genetic variation
MeSH terms
Clinical Studies as Topic, Central Nervous System Stimulants, Animals, Disease Models, Animal, Disease Susceptibility, Humans, Nicotine, Reinforcement, Psychology, Signal Transduction, Biomarkers, Substance-Related Disorders, Genetic Predisposition to Disease, Ghrelin, Receptors, Ghrelin, Tobacco Use

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Ghrelin/GHS-R1A Signaling in Nonalcohol Drug Addictions. https://app.cochat.ai/papers/10.3390/ijms23020761
The paper
Sustkova-Fiserova, M., Charalambous, C., Khryakova, A., Certilina, A., Lapka, M., & Šlamberová, R. (2022). The Role of Ghrelin/GHS-R1A Signaling in Nonalcohol Drug Addictions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms23020761

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.